Evidence map›Paper›PMID 35928621›Full record

ArticleJournal of thoracic disease2022

Sheng Wei, Jingjing Shao, Jinming Wang, Tianye Zhao, Jia Liu, Xiying Shen, Yidan Wang, Haizhen Chen, Gaoren Wang

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. EHD2, a novel HIF target gene, is a promising biomarker in clear cell renal cell carcinoma.International journal of clinical and experimental pathology · 2023
    Article
  6. Article
  7. CMaf-Inducing Protein Promotes LUAD Proliferation and Metastasis by Activating the MAPK/ERK Pathway.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sheng Wei *Department of Radiotherapy, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Jingjing Shao *Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Jinming WangDepartment of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Tianye ZhaoKey Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Jia LiuKey Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Xiying ShenKey Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Yidan WangKey Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Haizhen ChenKey Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Gaoren WangDepartment of Radiotherapy, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, China.
Nantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: EH domain contains protein 2 ( Methods: The link between Results: The results indicated that Conclusions: Our study demonstrated that

Indexed as

EHD2epithelial-mesenchymal transition (EMT)Lung adenocarcinomaoverall survival (OS)

Identifiers

PMID35928621
PMCPMC9344424
OpenAlexW4285818229

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.